Roper CEO Says 75% Of CentraReach Bookings Are AI-Related, But Calls Wider Success 'Still To Be Proven'

Neil Hunn put AI at about 25% of Aderant bookings but would not say how large the share gets across the portfolio.

Share
Roper CEO Says 75% Of CentraReach Bookings Are AI-Related, But Calls Wider Success 'Still To Be Proven'

Roper Technologies CEO Neil Hunn said on the company's third-quarter earnings call that about 75% of bookings at its CentraReach unit are AI-specific or AI-related, and about 25% at Aderant. He would not say how big that share gets across the portfolio, calling it "too early."

A wide range, and a year's head start

Pressed by a Wolfe Research analyst on where AI monetization is visible today, Hunn asked CFO Jason Conley to keep him honest on the numbers, then gave the 75% figure for CentraReach and roughly 25% for Aderant. He called the spread "a wide range."

He said those two units "were, I don't know, a year ahead of the portfolio," and that the rest is catching up. Whether AI-related bookings end up at 10%, 25% or 50% of the total is, he said, too early to say.

Roper, a diversified technology company, owns vertical software businesses and technology-enabled products for niche markets. The company reported revenue of $2.2 billion for the quarter, up 8%, with organic growth of 7%. Adjusted earnings per share rose 15% to $5.89, above the company's guided range of $5.75 to $5.80.

Launches without a flop, adoption still slow

Hunn said 17 or 18 of Roper's 21 software businesses have agentic products, meaning AI that carries out tasks, in the market. He said the company has not had "any abject, out-of-the-box failures." The three businesses without an AI tool are a group purchasing organization and two clinical-diagnostics lab-software units, which he described as already largely automated.

He called this year one of "commercialization learnings" and said early indications are positive, but "it's still to be proven." Budget cycles, AI committees and data-governance safeguards are slowing sales, and hospitals add an AI governance review on top of the traditional sales cycle, he said.

Hunn described three pricing models. The most common is a fixed block of usage bought up front and treated as recurring revenue. Others are pure per-use pricing, such as per prescription or per freight load, and add-on cloud upgrades at higher prices, as at Deltek.

He said gross margins on the agentic tools are in line with Roper's software margins.

Raised outlook and a $180 billion target

Roper raised and narrowed full-year adjusted earnings per share guidance to a range of $22.35 to $22.40, up $0.15 at the midpoint from its prior guide. For the fourth quarter it guided to $5.95 to $6.00, and it expects total revenue growth north of 8% for the year.

Among the new products Hunn cited is PowerPlan's tool for the more than $180 billion of capital investment at U.S. electric utilities awaiting detailed asset classification. He said customers finish work in minutes that used to take days or weeks.

Roper put $436 million into three bolt-on acquisitions for iPipeline, Procare and Strata in the quarter. Leverage stands at 2.9 times, and Hunn said the company has over $6 billion of capital deployment capacity over the next 12 months.

Hunn said Roper's 2027 planning with all of its companies starts next week, and he described the setup as "generally constructive."

Sources

More on Roper Technologies

All Roper Technologies (ROP) coverage →